title: Single-cell transcriptome in the identification of disease biomarkers: opportunities and challenges.
abstract: Single cell transcriptome defined as the entire RNA or polyadenylated products of RNA polymerase II on a cell can describe the gene regulation networks responsible for physiological functions, behaviours, and phenotypes in response to signals and microenvironmental changes. Single cell transcriptome/sequencing has the special power to investigate small groups of differentiating cells, circulating tumour cells, or tissue stem cells. A large number of factors may influence the extent of single-cell heterogeneity within a system. It is the opportunity that the single-cell sequencing can be used for the identification of genetic changes in rare cells, e.g. cancer and tissue stem cells, in clinical samples. The methodologies of single-cell sequencing have been improved and developed with the increase of the understanding and attention. The clinical research and application of the single cell sequencing analysis are expected to identify and validate disease-specific biomarkers, network biomarkers, dynamic network biomarkers. The single cell research and value will be also dependent upon the understanding of genomic heterogeneity, planning and design of study protocol, representative of selected and targeted cells, and sensitivity and repeatability of the methodology. The single cell sequencing can be used to develop new diagnostics, monitor disease progresses, measure responses to therapies, and predict the prognosis of patients, although there are still a large number of challenges and difficulties to be faced. It would be more values and specificities of the single cell sequencing to integrate with the function of cells, organs, and systems of the body, the clinical phenotypes of patients, and the description of clinical bioinformatics.
authors.forename: Zhitu
authors.initials: Z
authors.lastname: Zhu
authors.forename: Diane C
authors.initials: DC
authors.lastname: Wang
authors.forename: Laurenţiu M
authors.initials: LM
authors.lastname: Popescu
authors.forename: Xiangdong
authors.initials: X
authors.lastname: Wang
mesh_terms: D004194:Disease / Q000235:genetics*; D020869:Gene Expression Profiling / Q000379:methods*; D018740:Genetic Heterogeneity; D005819:Genetic Markers; D006801:Humans; D017423:Sequence Analysis, RNA; D059010:Single-Cell Analysis / Q000379:methods*; D059467:Transcriptome
chemical_list: D005819:Genetic Markers
references.citation: Cell Stem Cell. 2010 May 7;6(5):468-78
references.pmid: 20452321
references.citation: Med Res Rev. 2014 May;34(3):455-78
references.pmid: 23775602
references.citation: J Cell Mol Med. 2013 Apr;17(4):567-77
references.pmid: 23621815
references.citation: Nucleic Acids Res. 2013 Jul;41(12):6119-38
references.pmid: 23630320
references.citation: Nat Methods. 2014 Jan;11(1):22-4
references.pmid: 24524133
references.citation: J Cell Mol Med. 2012 Jun;16(6):1286-97
references.pmid: 21883889
references.citation: Genome Med. 2013 Aug 27;5(8):74
references.pmid: 23998189
references.citation: Nat Rev Genet. 2013 Sep;14(9):618-30
references.pmid: 23897237
references.citation: Clin Transl Med. 2012 Sep 05;1(1):20
references.pmid: 23369623
references.citation: Nature. 2013 Jun 13;498(7453):236-40
references.pmid: 23685454
references.citation: J Clin Bioinforma. 2011 Oct 24;1(1):28
references.pmid: 22024468
references.citation: Cell Stem Cell. 2013 Oct 3;13(4):492-505
references.pmid: 24035353
references.citation: Nat Methods. 2011 Apr;8(4 Suppl):S6-11
references.pmid: 21451510
references.citation: Nat Methods. 2014 Jan;11(1):19-21
references.pmid: 24524132
references.citation: Curr Opin Genet Dev. 2014 Feb;24:82-91
references.pmid: 24531336
references.citation: Mol Cell Ther. 2013 Nov 06;1:1
references.pmid: 26056567
references.citation: PLoS Genet. 2014 Jan 30;10(1):e1004126
references.pmid: 24497842
references.citation: Cell. 2012 Jul 20;150(2):402-12
references.pmid: 22817899
references.citation: Genome Med. 2011 May 31;3(5):31
references.pmid: 21631906